President Trump has initiated probes into pharmaceutical and chip imports, which could lead to new tariffs. This move sets the stage for potential tariffs on these critical industries, posing significant political risks. The investigation into drug imports has raised concerns about possible shortages and price hikes. Meanwhile, the probe into chip and electronics imports indicates a broader strategy to impose tariffs on key technology sectors. These actions come amid ongoing scrutiny of international trade practices and their impact on the U.S. economy. — new from The New York Times